HomeStock ScreenerEnvair ElectrodyneIntrinsic Value

Envair Electrodyne Intrinsic Value

Envair Electrodyne (ENVAIREL) median intrinsic value is ₹26.93 from 2 valuation models (range ₹18–₹27), vs current price ₹89.76 — -70.0% downside (Trading Above Calculated Value), margin of safety -100.0%. Also explore ENVAIREL price movement history to track price trends across different timeframes.

Current Stock Price
₹89.76
Primary Intrinsic Value
₹17.95
Market Cap
₹44.9 Cr
-70.0% Downside
Median Value
₹26.93
Value Range
₹18 - ₹27
Assessment
Trading Above Calculated Value
Safety Margin
-100.0%

ENVAIREL Valuation Methods Summary — DCF, Graham Number & P/E

Envair Electrodyne intrinsic value across 2 models vs current price ₹89.76 — upside/downside and value range per method. For current market price and key ratios, visit Envair Electrodyne share price screener.

Method Type Intrinsic Value Range Upside/Downside Details
Book Value Method asset ₹17.95 ₹16.16 - ₹19.75 -80.0% Book Value/Share: ₹16.00, P/B: 1.0x
Revenue Multiple Method revenue ₹26.93 ₹24.24 - ₹29.62 -70.0% Revenue/Share: ₹2.00, P/S: 0.8x
Method Types: Earnings Asset DCF Growth Dividend Conservative

ENVAIREL Intrinsic Value vs Market Price — All Valuation Models

Envair Electrodyne fair value range ₹18–₹27 vs current market price ₹89.76 across 2 valuation models. Browse ENVAIREL cash flow statement for revenue, profit, balance sheet and cash flow data.

ENVAIREL Intrinsic Value Analysis — Undervalued or Overvalued?

Envair Electrodyne median intrinsic value ₹26.93, current price ₹89.76 — Trading Above Calculated Value by 70.0%, margin of safety -100.0%.

What is the intrinsic value of ENVAIREL?

Based on our comprehensive analysis using 2 different valuation methods, the estimated intrinsic value of Envair Electrodyne (ENVAIREL) is ₹26.93 (median value). With the current market price of ₹89.76, this represents a -70.0% variance from our estimated fair value.

The valuation range spans from ₹17.95 to ₹26.93, indicating ₹17.95 - ₹26.93.

Is ENVAIREL undervalued or overvalued?

Based on our multi-method analysis, Envair Electrodyne (ENVAIREL) appears to be trading above calculated value by approximately 70.0%.

ENVAIREL Financial Health — Key Ratios vs Industry Benchmarks

Envair Electrodyne financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.

Financial Metric Current Value Industry Benchmark Assessment Impact on Valuation
Asset Turnover Ratio 0.11x Industry Standard: 1.0x+ Below 0.5x Measures asset utilization efficiency

ENVAIREL Cash Flow Quality — Operating & Free Cash Flow

Envair Electrodyne operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.

Period Operating Cash Flow Free Cash Flow Cash Flow Quality Sustainability Score
March 2025 ₹0 Cr ₹-3 Cr Negative Cash Flow 3/10
March 2024 ₹6 Cr ₹6 Cr Positive Free Cash Flow 8/10
March 2023 ₹-9 Cr ₹-9 Cr Negative Cash Flow 3/10
March 2022 ₹-2 Cr ₹-2 Cr Negative Cash Flow 3/10
March 2021 ₹-2 Cr ₹-3 Cr Negative Cash Flow 3/10